KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Net LoansChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Long-Term Debt Repayments (2016 - 2025)

Healthpeak Properties (DOC) has disclosed Long-Term Debt Repayments for 12 consecutive years, with $940000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 96.04% to $940000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $807.4 million, a 2915.06% increase, with the full-year FY2025 number at $807.4 million, up 2915.06% from a year prior.
  • Long-Term Debt Repayments was $940000.0 for Q4 2025 at Healthpeak Properties, up from $916000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.5 billion in Q1 2021 to a low of $861000.0 in Q1 2024.
  • A 5-year average of $167.8 million and a median of $1.3 million in 2023 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: tumbled 99.91% in 2022, then surged 40980.94% in 2025.
  • Healthpeak Properties' Long-Term Debt Repayments stood at $4.3 million in 2021, then tumbled by 70.29% to $1.3 million in 2022, then surged by 6584.33% to $86.2 million in 2023, then tumbled by 72.44% to $23.7 million in 2024, then crashed by 96.04% to $940000.0 in 2025.
  • Per Business Quant, the three most recent readings for DOC's Long-Term Debt Repayments are $940000.0 (Q4 2025), $916000.0 (Q3 2025), and $452.7 million (Q2 2025).